| Typicality: | 0.509 |
| Saliency: | 0.228 |
| for individuals with a bleeding disorder | 8 | transitive-object |
| to reduce the risk | 7 | purpose |
| with booster doses | 2 | other |
| vaccine → be given by → deep subcutaneous injection | 8 |
| vaccine → be administered by → subcutaneous route | 5 |
| vaccine → be given in → subcutaneous tissue | 3 |
| negative | neutral | positive |
| 0.191 | 0.749 | 0.060 |
| Raw frequency | 16 |
| Normalized frequency | 0.228 |
| Modifier score | 1.000 |
| Perplexity | 26.637 |